HIV Medications for HIV Prevention: News & Research
- Chicago Team Responds to HIV Drug Study (December 17, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Steve Gibson on PrEP: Your Questions Answered (December 16, 2010)
From San Francisco AIDS Foundation
- Promising HIV Prevention Offers Some New Hope (December 14, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- California: Preventive Drug Brings Promise -- and Questions (December 13, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- After HIV Pill News, Now Comes the Tricky Part (December 8, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- iPrEx: A Tenofovir/Emtricitabine Pill a Day Keeps the HIV (Doctor) Away (December 8, 2010)
Part of "Top HIV/AIDS-Related Clinical Developments of 2010," by David Wohl, M.D.
From TheBody.com
- CAPRISA: A Home Run (or at Least a Base Hit) for a Microbicide (December 8, 2010)
Part of "Top HIV/AIDS-Related Clinical Developments of 2010," by David Wohl, M.D.
From TheBody.com
- PrEP: What Does It Mean for Women? (December 8, 2010)
From Global Campaign for Microbicides
- Questions and Answers: Global Pre-Exposure Prophylaxis Initiative (iPrEx) Study (December 8, 2010)
From Global Campaign for Microbicides
- The Role of ARVs in HIV Prevention: Microbicides and PrEP (December 2010)
To read PDF, click here.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Taken Preventively Daily HIV Meds Could Reduce HIV Risk Among Gay, Bisexual Men (November 30, 2010)
From Black AIDS Institute
- Chicago-Based Pre-Exposure Prophylaxis Study Team Responds to Recent iPrEx Study Results (November 29, 2010)
From Project PrEPare
- Hold the Celebrations: Antiretroviral Drugs Not Promised to Prevent HIV: A Blog Entry by Candace Y.A. Montague (November 28, 2010)
"Pills are great and the news of a new potential prevention method is still wonderful. But getting groups of people to see that they are at risk remains to be the challenge."
From TheBody.com
- CDC Statement on Results of iPrEx Trial Examining Pre-Exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex With Men (November 23, 2010)
From U.S. Centers for Disease Control and Prevention
- Global Campaign for Microbicides Lauds Milestone in HIV Prevention Findings That Daily Use of Anti-Retroviral Protects Against HIV Infection (November 23, 2010)
Results from global iPrEx trial offer hope for those at highest risk of infection.
From Global Campaign for Microbicides
- NIH-Funded Study Finds Daily Dose of Antiretroviral Drug Reduces Risk of HIV (November 23, 2010)
From AIDS.gov
- President Obama Welcomes New HIV Prevention Research Results (November 23, 2010)
From AIDS.gov
- The Future of PrEP: Questions and Next Steps Following the iPrEx Study Results (November 23, 2010)
From Project Inform
- Daily Oral Antiretroviral Reduces HIV Infection Risk in MSM by 44%, Study Finds (November 23, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
 iPrEx: First-Ever PrEP Efficacy Study Published (November 23, 2010)
Paul Sax, M.D., offers his analysis of the study results and their real-world implications.
From Journal Watch
- Daily Dose of Truvada Reduces HIV Infection Risk by 44 Percent Among Gay Men, Study Finds (November 23, 2010)
From U.S. National Institute of Allergy and Infectious Diseases
|
Advertisement
|
Email
Glossary
